A randomized, cross‐over trial of metoprolol succinate formulations to evaluate <scp>PK</scp> and <scp>PD</scp> end points for therapeutic equivalence-Reference-Cited by-同舟云学术

A randomized, cross‐over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence

Published:2022-05-21 Issue:7 Volume:15 Page:1764-1775
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Mosley Scott A.¹²^ORCID,Kim Sarah³^ORCID,El Rouby Nihal¹⁴^ORCID,Lingineni Karthik³,Esteban Valvanera Vozmediano³,Gong Yan¹^ORCID,Chen Yiqing¹,Estores David⁵,Feng Kairui⁶,Kim Hyewon⁶,Kinjo Minori⁶,Langaee Taimour¹,Li Zhichuan⁶,Schmidt Siegfried O. F.⁷,Johnson Julie A.¹,Frye Reginald F.¹^ORCID,Fang Lanyan (Lucy)⁶,Zhao Liang⁶,Binkley Philip F.⁸,Schmidt Stephan³,Cavallari Larisa H.¹^ORCID

Affiliation:

1. Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine College of Pharmacy, University of Florida Gainesville Florida USA

2. Department of Clinical Pharmacy University of Southern California Los Angeles California USA

3. Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy University of Florida Orlando Florida USA

4. Department of Pharmacy Practice and Administrative Sciences University of Cincinnati Cincinnati Ohio USA

5. Division of Gastroenterology, Hepatology, and Nutrition College of Medicine, University of Florida Gainesville Florida USA

6. Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA

7. Department of Community Health and Family Medicine College of Medicine, University of Florida Gainesville Florida USA

8. Division of Cardiovascular Medicine, College of Medicine The Ohio State University Columbus Ohio USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13294

Reference46 articles.

1. In search of autonomic balance: the good, the bad, and the ugly

2. Long-term carvedilol therapy increases parasympathetic nervous system activity in chronic congestive heart failure

3. Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure

4. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)

5. Real‐World Data Approaches for Early Detection of Potential Safety and Effectiveness Signals for Generic Substitution: A Metoprolol Extended‐Release Case Study